Treatment News : HIV Accelerates Liver Fibrosis by Nearly a Decade Among People With Hep C

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News » February 2013

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


February 28, 2013

HIV Accelerates Liver Fibrosis by Nearly a Decade Among People With Hep C

The severity of liver fibrosis among those coinfected with hepatitis C virus (HCV) and HIV is comparable to fibrosis found in people monoinfected with hep C who are nearly 10 years older, MedPage Today reports. Publishing the findings of their National Institute on Drug Abuse–funded study in the Annals of Internal Medicine, researchers at Johns Hopkins School of Medicine examined 1,176 current and former injection drug users living with HCV and compared liver fibrosis by age between monoinfected and coinfected patients. In addition to assessing liver fibrosis every six months between 2006 and 2011, the investigators took a medical history, asked questions about alcohol and drug use and measured HCV RNA levels, hepatitis B virus (HBV) surface antigen levels, body mass index (BMI) and, for the HIV-positive participants, CD4 counts and viral loads.

The median age of the cohort was 49, and 34 percent were coinfected. The investigators took 5,634 liver fibrosis measurements over the course of the study. Between the coinfected and monoinfected participants, the respective prevalence of clinically significant fibrosis without cirrhosis was 12.9 and 9.5 percent; the respective prevalence of cirrhosis was 19.5 and 11 percent. Variables independently associated with liver fibrosis were older age, HIV infection, daily alcohol use, chronic hepatitis B infection, a BMI above 25 kg/m2 and higher HIV viral load. Factoring out these other variables, coinfected people had liver fibrosis measurements equivalent to monoinfected participants who were an average of 9.2 years older. The study is limited by the fact that liver fibrosis had already begun for most participants before they entered the study.

To read the MedPage Today report, click here.

To read the study abstract, click here

Search: HIV, hepatitis C, coinfection, liver fibrosis, Annals of Internal Medicine, Johns Hopkins School of Medicine, hepatitis B, body mass index, CD4 count, viral load, accelerated.

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (0 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.